Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China
· Delayed Price · Currency is CNY 10.09
+0.43 (4.45%)
Apr 29, 2026, 3:04 PM CST
SHE:300439 Revenue
In the year 2025, Medicalsystem Biotechnology had annual revenue of 1.54B CNY, down -11.67%. Medicalsystem Biotechnology had revenue of 403.49M in the quarter ending December 31, 2025, with 20.19% growth.
Revenue
1.54B
Revenue Growth
-11.67%
P/S Ratio
2.41
Revenue / Employee
731.54K
Employees
2,104
Market Cap
3.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.54B | -203.26M | -11.67% |
| Dec 31, 2024 | 1.74B | -143.44M | -7.61% |
| Dec 31, 2023 | 1.89B | -603.22M | -24.23% |
| Jan 1, 2023 | 2.49B | 237.55M | 10.55% |
| Dec 31, 2021 | 2.25B | -50.50M | -2.19% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Labway Clinical Laboratory | 1.52B |
| Guangdong Hybribio Biotech | 691.16M |
| Berry Genomics Co.,Ltd | 941.16M |
| SMO ClinPlus CO.,LTD. | 819.09M |
| Thalys Medical Technology Group | 1.25B |
| Chemclin Diagnostics | 353.32M |
| Shanghai Rendu Biotechnology | 162.06M |
| Cowealth Medical China | 656.38M |